Standout Papers
Immediate Impact
59 standout
Citing Papers
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
Bispecific antibody drug conjugates: Making 1+1>2
2024 Standout
Works of Giovanni Cappello being referenced
Phase II study of anti-EGFR rechallenge therapy with panitumumab driven by circulating tumor DNA molecular selection in metastatic colorectal cancer: The CHRONOS trial.
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Giovanni Cappello | 87 | 108 | 93 | 38 | 397 | |
| Max Sauter | 30 | 118 | 119 | 39 | 454 | |
| Mika Inoue | 35 | 21 | 63 | 36 | 410 | |
| Yusaku Akashi | 83 | 96 | 35 | 38 | 438 | |
| Rajyasree Emmadi | 54 | 106 | 36 | 31 | 442 | |
| Reinhard Spanel | 26 | 95 | 44 | 22 | 344 | |
| Manon Roche | 88 | 68 | 55 | 22 | 372 | |
| Elijah F. Edmondson | 117 | 146 | 143 | 44 | 458 | |
| Xiuyu Song | 55 | 67 | 31 | 28 | 379 | |
| Cooper Jf | 67 | 50 | 30 | 19 | 351 | |
| Kyeongmin Kim | 86 | 82 | 79 | 32 | 416 |
All Works
Login with ORCID to disown or claim papers
Loading papers...